Krumax Pharmaceuticals Private Limited
About Krumax Pharmaceuticals Private Limited
Data last updated:
Krumax Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 13 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24110UP2019PTC114599.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Kumar Kailash Narayan Gupta and Anjali Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 286 F – 1 Sector – 12 Pratap Vihar, Ghaziabad, Uttar Pradesh, India – 201009.
As per the financials filed for FY 2025, the company reported a revenue of ₹25,000, a growth of 117% compared to the previous year. For the same year it recorded a net profit of ₹646 (net margin 2.6%) and EBITDA of ₹876 (EBITDA margin 3.5%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressM – 286 F – 1 Sector – 12 Pratap Vihar, Ghaziabad, Uttar Pradesh, India – 201009
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Krumax Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Krumax Pharmaceuticals Private Limited
FY 2025 filings availableKrumax Pharmaceuticals Private Limited reported revenue of ₹25,000 (up 117% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 117% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 42%. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹876 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹646 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.5% | |
| Net Profit Margin | 2.6% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Krumax Pharmaceuticals are in the company report.
: available in the company report
Board of Directors of Krumax Pharmaceuticals Private Limited
Krumax Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Kailash Narayan Gupta | Director | 13 Mar 2019 | 7 Years 7 Months | Current |
| Anjali Gupta | Additional Director | 14 Jan 2022 | 4 Years 9 Months | Current |
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Krumax Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Krumax Pharmaceuticals.
: available in the company report
Recent Activity
Krumax Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Anjali Gupta was appointed as Additional Director on 14 Jan 2022.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Krumax Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 13 March 2019 (7+ years old) and is registered under CIN U24110UP2019PTC114599.
Krumax Pharmaceuticals has 2 current directors:
- Ajay Kumar Kailash Narayan Gupta - Director
- Anjali Gupta - Additional Director
The latest financial statements of Krumax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Krumax Pharmaceuticals is U24110UP2019PTC114599. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Krumax Pharmaceuticals was incorporated on 13 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Anjali Gupta was appointed as Additional Director on 14 Jan 2022. Sachin Kumar Tiwari ceased to be Director on 14 Jan 2022. Ajay Kumar Kailash Narayan Gupta was appointed as Director on 13 Mar 2019.
The registered office of Krumax Pharmaceuticals is at M – 286 F – 1 Sector – 12 Pratap Vihar, Ghaziabad, Uttar Pradesh, India – 201009.
Krumax Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Krumax Pharmaceuticals can be reached at its registered office: M – 286 F – 1 Sector – 12 Pratap Vihar, Ghaziabad, Uttar Pradesh, India – 201009.
Krumax Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.